Market Overview - Global financial markets are experiencing optimism due to positive U.S.-China trade relations, a pharmaceutical breakthrough in Canada, and strong industrial profit growth in China [2][6] - U.S. pre-market indicators show S&P 500 futures up 0.9%, Nasdaq-100 futures up 1.3%, and Russell 2000 futures up 1% [2] Pharmaceutical Industry - Health Canada has granted conditional authorization for Eisai Co., Ltd. and Biogen Inc.'s drug LEQEMBI® (lecanemab) for early Alzheimer's disease, marking it as the first treatment targeting the underlying cause in Canada [3][8] - The approval is based on positive results from the Phase 3 Clarity AD study, where LEQEMBI reduced cognitive decline by 27% over 18 months compared to placebo [4] - The drug is already approved in 51 other countries, with significant implications for the estimated 771,000 Canadians living with dementia [4] Industrial Sector in China - China's industrial profits have seen substantial growth, attributed to government efforts to address industrial overcapacity and improve profitability [5][8] - These proactive measures are contributing to a more stable and profitable industrial landscape in China [5] Individual Stock Movements - Keurig Dr Pepper (KDP) shares rose 3.5% after reporting revenues that exceeded expectations and raising its full-year net sales growth outlook [7][8] - Carter's (CRI) shares fell 9% due to missed sales and operating margin targets [8][11] - Snowflake (SNOW) shares gained 2% after reaffirming its revenue guidance for the third quarter and fiscal year 2026 [11] - Cadence Bank (CADE) also saw a positive movement, increasing by 3.5% [11]